NHSA Holds Forum on Supporting the Global Expansion of China's Pharmaceuticals and Medical Devices via the Centralized Procurement Trading and Pricing Platform

Representatives from relevant state ministries and commissions introduced policy measures to support China's pharmaceuticals and medical devices sector. Financial institution representatives presented full-cycle financial service solutions tailored for Chinese pharmaceutical and medical device enterprises. Enterprise representatives shared their experience in expanding and practicing overseas markets, and put forward constructive suggestions for the platform's development.

The forum was attended by notable guests including Li Kebin, person in charge of the China Pharmaceutical Price Registration System; Wu Gang, Second-Class Inspector of Tianjin Healthcare Security Bureau and representative of the China International Medical Equipment and Device Trading (Centralized Procurement) Platform; Zheng Jinda, Director of Ningbo Healthcare Security Bureau and representative of the Ningbo China-CEEC (Centralized Procurement) Trading Platform (in preparation); Lai Yongdong, Deputy Director of Guangxi Healthcare Security Bureau and representative of the China-ASEAN (Centralized Procurement) Trading Platform; Abudurexiti Tusong, Deputy Director of Xinjiang Healthcare Security Bureau and representative of the China-Central Asia "Central Pharmacy"; Han Wen, Deputy General Manager of the Corporate Banking and Investment Banking Department of Bank of China; Bai Jianhui, Assistant General Manager of the Corporate Business Department of China Eximbank; Hong Libin, Co-Head of the Healthcare and Health Industry at the Investment Banking Department of CITIC Securities; Song Shuo, Chief Analyst of the Medical Industry Chain at the Research Department of CITIC Securities; Zhang Hanchang, Vice President of Qilu Pharmaceutical Group Co., Ltd.; Wang Feng, Chief Executive Officer of Efann Pharmaceutical Co., Ltd.; Sun Weisen, Vice President of Shanghai United Imaging Healthcare Co., Ltd.; Wang Shu, Deputy General Manager of the Business Management Department of China Export & Credit Insurance Corporation; and Zhou Ye, Vice President of Jiangsu Hengrui Medicine Co., Ltd..

The NHSA has fully deployed the strategy to support the global expansion of China's pharmaceuticals and medical devices, listing the following as a key task for 2026: "Leveraging the regional advantages of various centralized procurement trading platforms to develop an innovative model for international procurement of pharmaceuticals and medical devices under the healthcare security system, giving full play to the multi-dimensional price discovery function of the China Pharmaceutical Price Registration System, and elevating the internationalization level of China's pharmaceutical industry".

The NHSA is actively promoting the distinctive and differentiated development of pharmaceuticals and medical devices (centralized procurement) trading and pricing platforms in Guangxi, Xinjiang, Tianjin, Ningbo (Zhejiang) and other regions, building such platforms targeting Southeast Asia, Central Asia and other co-construction countries of the Belt and Road Initiative. It is also guiding the development of the China Pharmaceutical Price Registration System, providing enterprises with authoritative, standardized and transparent global market price registration and inquiry services to support them in building a global pharmaceutical pricing system. The NHSA is striving to build China into the world's most important launchpad for innovative drugs and a global benchmark for innovative drug pricing.

This forum aims to build a closely integrated ecosystem of "government, industry, finance and services" based on the National Healthcare Security Pharmaceuticals and Medical Devices (Centralized Procurement) Trading and Pricing Platform, empower and support the global expansion of China's pharmaceuticals and medical devices, enable the world to share the fruits of the innovative development of China's pharmaceutical industry, and demonstrate China's responsibility in building a global community of health for all.

China Healthcare Security, lifelong protection! Everyone is responsible for safeguarding the security of the healthcare security fund!